ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352122 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352122; 2) Community: the network communities that were significantly associated with the response to NSC 352122; 3) Molecule: the relationships between components within communities and NSC 352122; 4) MDR: the compounds that were significantly associated with the NSC 352122.

NSC Compound Enrichment Correlation
NSC 694619 Null 0.0480633950058475 0.23972852
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0480633950058475 0.29663891
NSC 718630 Null 0.0480633950058475 0.42451903
NSC 718781 Erlotinib hydrochloride 0.0480633950058475 -0.26642963
NSC 725098 Null 0.0480633950058475 0.47062054
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0480633950058475 0.32693972
NSC 726217 Combretastatin A4-analogue 0.0480633950058475 0.39773594
NSC 726578 Null 0.0480633950058475 0.38208887
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0480633950058475 0.55889824
NSC 730691 Null 0.0480633950058475 0.38751351
Total:67  Current:66    [First] [Prev] [Next] [Last]